IBM spokesman Ian Colley said that the company's results have been hurt
by currency shifts and business divestitures.
Not exact matches
«There is an important
shift in the industry that is driven
by mobile technology at the point - of - sale, integrated with a finance marketplace that is finding innovative ways to help small business get funding for mission - critical equipment, said CEMC founder and
currency CEO, Charles Anderson.
«The most significant drag is primarily felt
by emerging market economies, who tend to be more sensitive to
shifts in global risk sentiment, which can also have large adverse effects on capital flows and
currency valuations,» the note said.
Earnings before interest, taxes and one - time items rose 20 % to 4.13 billion kroner ($ 652 million), beating estimates of 3.82 billion kroner Sales rose 2 % on a basis that excludes
currency and acquisition effects, compared with analysts projections for growth of 3.2 % Debt reduced
by 14 % to 21.9 billion kroner Carlsberg reduced its full - year forecast for gains from
currency shifts to 50 million kroner from 300 million kroner.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated
shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign
currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The race between automation and human work is won
by automation, and as long as we need fiat
currency to pay the rent / mortgage, humans will fall out of the system in droves as this
shift takes place... The safe zones are services that require local human effort (gardening, painting, babysitting), distant human effort (editing, coaching, coordinating), and high - level thinking / relationship building.
At dispute is an alleged deficit that amounts to less than two per cent of $ 630 billion (U.S.) in annual Canada-U.S. trade, and the final result can be made or broken
by a small
shift in energy prices and
currency values.
In sum, the U.S. payments deficit and central bank movements out of the dollar, aggravated
by U.S. military activity in Iraq and other countries, may indeed trigger a
shift of international
currency holdings into euros.
COGS per hectoliter decreased 5.9 percent in local
currency due to cost savings and lower pension and distribution costs, partially offset
by the impact of volume deleverage, inflation, mix
shift to higher - cost brands, and foreign
currency movements.
Revenue rose
by 4 % to $ 16.3 billion, but that boost was almost entirely powered
by foreign
currency shifts.
However, a
shift by financial intermediaries towards borrowing in euros and UK pounds, as they seek to diversify their funding sources, saw those
currencies» share of offshore foreign
currency issuance increase sharply to almost 30 per cent.
Fearing demonetisation - like action from the government and faced with intermittent raids
by the market regulator, several dabba traders have
shifted to organised trading platforms across the commodity, equity and
currency sectors.
Sjors has already had a tremendous impact on the way millions of people use digital
currencies, but I'm excited to see him continue making that impact, across an even greater user base
by shifting his focus to the protocols themselves.
By adopting this hard fork, we believe the supporters of this agreement are
shifting their users to an alternative
currency (an altcoin) which is incompatible with Bitcoin.
Buyers may be surprised
by how the purchasing power of major
currencies has
shifted in the past year, driven
by the strength of the U.S. dollar.